Corriente Advisors, LLC
- SEC CIK
- 0001406718
- Latest filing
- Feb 14, 2024
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 8
- −7 vs. Q2 2021
- Portfolio value
- $51.8M
- −$133.6M (−72.1%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CUECue Biopharma, Inc. | COM | 948,389 | $13.8M | 26.7% | −538,597−36.2% | Reduced | History |
| SWNSouthwestern Energy Co | COM | 1,550,000 | $8.59M | 16.6% | +1,550,000 | New | History |
| TFFPTFF Pharmaceuticals, Inc. | COM | 1,019,848 | $7.87M | 15.2% | +1,019,848 | New | History |
| LTRNLantern Pharma Inc. | COM | 625,873 | $7.00M | 13.5% | −30,491−4.6% | Reduced | History |
| VETVermilion Energy Inc. | COM | 700,000 | $6.91M | 13.3% | +700,000 | New | History |
| CVECenovus Energy Inc. | COM | 540,000 | $5.44M | 10.5% | +540,000 | New | History |
| Sprott Physical Uranium Unt85210A104 | COM | 153,400 | $1.74M | 3.4% | +153,400 | New | – |
| CCJCameco Corp | Stock | 20,000 | $435.0K | 0.8% | +20,000 | New | History |
Sold out since Q2 2021 (13)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| MAXRMaxar Technologies Inc. | COM | 1,920,333 | $76.7M | 41.3% | History |
| REPLReplimune Group, Inc. | COM | 449,879 | $17.3M | 9.3% | History |
| COINCoinbase Global, Inc. | COM CL A | 40,000 | $10.1M | 5.5% | History |
| RETAReata Pharmaceuticals Inc | CL A | 71,115 | $10.1M | 5.4% | History |
| QSQuantumScape Corp | COM CL A | 337,316 | $9.87M | 5.3% | History |
| CRDFCardiff Oncology, Inc. | COM | 1,383,500 | $9.20M | 5.0% | History |
| KTOSKratos Defense & Security Solutions, Inc. | COM NEW | 275,738 | $7.86M | 4.2% | History |
| MPMP Materials Corp. | COM CL A | 110,000 | $4.05M | 2.2% | History |
| HIMXHimax Technologies, Inc. | SPONSORED ADR | 200,000 | $3.33M | 1.8% | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 20,000 | $3.24M | 1.7% | History |
| IRDMIridium Communications Inc. | COM | 80,000 | $3.20M | 1.7% | History |
| RBLXRoblox Corp | Stock | 30,000 | $2.70M | 1.5% | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 203,641 | $906.0K | 0.5% | History |